Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06551701 · ClinicalTrials.gov registry record
ACHIEVE Pilot Statins for Vascular Protection
A clinical trial of ASCVD, sponsored by Duke University.
- Active
- Registry status
- 225
- Enrollment target
- 2
- Study locations
NCT06551701: Active study of ASCVD, sponsored by Duke University.
NCT06551701 is a study of ASCVD that is active but no longer recruiting, run by Duke University. The registered enrollment target is 225 participants, below the 13,407-participant average among 5 other ASCVD trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06551701, a study of ASCVD, is active but no longer recruiting, sponsored by Duke University.
- ACTIVE NOT RECRUITING
- Registry status
- 225 participants
- Enrollment target
- 2
- Study locations
Study Summary
ACHIEVE aims to increase statin usage among patients with ASCVD by having a pharmacist talk to patients and providers.
Primary Outcome
The goal is recruiting at least 25% of identified providers.
Conditions Studied
Interventions
- OTHER Pharmacist call
Study Locations (2)
Delaware
- Carelon Research - Wilmington
North Carolina
- Duke Clinical Research Institute - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2025-05-19 |
| Est. Completion | 2026-02-28 |
What the registry record for NCT06551701 still lists
NCT06551701 is an observational study that tracks outcomes without assigning an intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 13,407-participant average among 5 other ASCVD trials with a reported enrollment target (98% lower).
The record links to 1 condition, with ASCVD appearing as the primary indexed condition, and to 1 intervention - of which Pharmacist call is the first listed.
NCT06551701 reports a single indexed study location in Delaware, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06551701 about?
NCT06551701 is a clinical study titled "ACHIEVE Pilot Statins for Vascular Protection". ACHIEVE aims to increase statin usage among patients with ASCVD by having a pharmacist talk to patients and providers.
What is the current status of trial NCT06551701?
This trial is currently active not recruiting. The enrollment target is 225 participants. The study started on 2025-05-19. Estimated completion is 2026-02-28.
What conditions does trial NCT06551701 study?
This clinical trial studies the following conditions: ASCVD.
What interventions are being tested in trial NCT06551701?
The interventions under investigation include: Pharmacist call (OTHER).
Who is sponsoring clinical trial NCT06551701?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06551701 being conducted?
This trial has 2 study locations across Delaware, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ASCVD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
RECRUITING · Phase 4
-
Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?
RECRUITING · NA
-
INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)
ACTIVE NOT RECRUITING
-
Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD)
ACTIVE NOT RECRUITING · NA
-
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Optimizing Low-Density Lipoprotein Management
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI